Zips D - Search Results

1

hERG K⁺ Channels Promote Survival of Irradiated Leukemia Cells.

Palme D, Misovic M, Ganser K, Klumpp L, Salih HR, Zips D, Huber SM. Palme D, et al. Among authors: zips d. Front Pharmacol. 2020 Apr 24;11:489. doi: 10.3389/fphar.2020.00489. eCollection 2020. Front Pharmacol. 2020. PMID: 32390841 Free PMC article.

2

Ca2+-Activated IK K+ Channel Blockade Radiosensitizes Glioblastoma Cells.

Stegen B, Butz L, Klumpp L, Zips D, Dittmann K, Ruth P, Huber SM. Stegen B, et al. Among authors: zips d. Mol Cancer Res. 2015 Sep;13(9):1283-95. doi: 10.1158/1541-7786.MCR-15-0075. Epub 2015 Jun 3. Mol Cancer Res. 2015. PMID: 26041939

3

BK K+ channel blockade inhibits radiation-induced migration/brain infiltration of glioblastoma cells.

Edalat L, Stegen B, Klumpp L, Haehl E, Schilbach K, Lukowski R, Kühnle M, Bernhardt G, Buschauer A, Zips D, Ruth P, Huber SM. Edalat L, et al. Among authors: zips d. Oncotarget. 2016 Mar 22;7(12):14259-78. doi: 10.18632/oncotarget.7423. Oncotarget. 2016. PMID: 26893360 Free PMC article.

4

Tumor-targeted IL-12 combined with local irradiation leads to systemic tumor control via abscopal effects in vivo.

Eckert F, Jelas I, Oehme M, Huber SM, Sonntag K, Welker C, Gillies SD, Strittmatter W, Zips D, Handgretinger R, Schilbach K. Eckert F, et al. Among authors: zips d. Oncoimmunology. 2017 Apr 28;6(6):e1323161. doi: 10.1080/2162402X.2017.1323161. eCollection 2017. Oncoimmunology. 2017. PMID: 28680762 Free PMC article.

5

TRPM8 is required for survival and radioresistance of glioblastoma cells.

Klumpp D, Frank SC, Klumpp L, Sezgin EC, Eckert M, Edalat L, Bastmeyer M, Zips D, Ruth P, Huber SM. Klumpp D, et al. Among authors: zips d. Oncotarget. 2017 Sep 30;8(56):95896-95913. doi: 10.18632/oncotarget.21436. eCollection 2017 Nov 10. Oncotarget. 2017. PMID: 29221175 Free PMC article.

6

Abscopal effects of radiotherapy and combined mRNA-based immunotherapy in a syngeneic, OVA-expressing thymoma mouse model.

Basler L, Kowalczyk A, Heidenreich R, Fotin-Mleczek M, Tsitsekidis S, Zips D, Eckert F, Huber SM. Basler L, et al. Among authors: zips d. Cancer Immunol Immunother. 2018 Apr;67(4):653-662. doi: 10.1007/s00262-018-2117-0. Epub 2018 Jan 16. Cancer Immunol Immunother. 2018. PMID: 29335856 Free PMC article.

7

Beyond checkpoint inhibition - Immunotherapeutical strategies in combination with radiation.

Eckert F, Gaipl US, Niedermann G, Hettich M, Schilbach K, Huber SM, Zips D. Eckert F, et al. Among authors: zips d. Clin Transl Radiat Oncol. 2017 Feb 4;2:29-35. doi: 10.1016/j.ctro.2016.12.006. eCollection 2017 Feb. Clin Transl Radiat Oncol. 2017. PMID: 29657997 Free PMC article. Review.

8

Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer.

Eckert F, Schilbach K, Klumpp L, Bardoscia L, Sezgin EC, Schwab M, Zips D, Huber SM. Eckert F, et al. Among authors: zips d. Front Immunol. 2018 Dec 21;9:3018. doi: 10.3389/fimmu.2018.03018. eCollection 2018. Front Immunol. 2018. PMID: 30622535 Free PMC article. Review.

9

Alternating Electric Fields (TTFields) Activate Ca_v1.2 Channels in Human Glioblastoma Cells.

Neuhaus E, Zirjacks L, Ganser K, Klumpp L, Schüler U, Zips D, Eckert F, Huber SM. Neuhaus E, et al. Among authors: zips d. Cancers (Basel). 2019 Jan 18;11(1):110. doi: 10.3390/cancers11010110. Cancers (Basel). 2019. PMID: 30669316 Free PMC article.

10

Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors.

Eckert F, Zwirner K, Boeke S, Thorwarth D, Zips D, Huber SM. Eckert F, et al. Among authors: zips d. Front Immunol. 2019 Mar 12;10:407. doi: 10.3389/fimmu.2019.00407. eCollection 2019. Front Immunol. 2019. PMID: 30930892 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

332 results

Search Page